Form 4: Vor Biopharma CEO Robert Ang Reports Stock Transaction
SEC Filing
Robert Ang, CEO of Vor Biopharma Inc., reports disposition of shares to cover tax obligations related to restricted stock units.
Summary
- On August 6, 2024, Robert Ang, the President and CEO of Vor Biopharma Inc., disposed of 2,361 shares of common stock to satisfy tax withholding obligations.
- The shares were sold at a price of $0.87 per share.
- Following the transaction, Ang beneficially owns 805,256 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade their company's stock. This provides transparency to the market.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small percentage of the CEO's holdings and is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/06/2024 | Date of stock transaction (disposal of shares). |
| 08/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.